VolitionRx (VNRX) Insider Trading & Ownership $0.64 +0.00 (+0.45%) Closing price 04:00 PM EasternExtended Trading$0.64 -0.01 (-1.09%) As of 05:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock VolitionRx (NYSE:VNRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$553.19KNumber OfInsiders Selling(Last 12 Months)0 Get VNRX Insider Trade Alerts Want to know when executives and insiders are buying or selling VolitionRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VNRX Insider Buying and Selling by Quarter VolitionRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/5/2025Cameron John ReynoldsCEOBuy78,125$0.64$50,000.00 8/5/2025Guy Archibald InnesDirectorBuy78,125$0.64$50,000.00 6/12/2025Cameron John ReynoldsCEOBuy12,500$0.59$7,375.00 6/3/2025Guy Archibald InnesDirectorBuy20,000$0.54$10,800.00 5/19/2025Cameron John ReynoldsCEOBuy20,000$0.44$8,800.00 5/19/2025Jacob Vincent MicallefInsiderBuy50,000$0.43$21,500.00 3/26/2025Cameron John ReynoldsCEOBuy181,818$0.55$99,999.90 12/9/2024Cameron John ReynoldsCEOBuy139,811$0.57$79,692.27 12/9/2024Guy Archibald InnesDirectorBuy174,764$0.57$99,615.48 12/9/2024Jacob Vincent MicallefInsiderBuy43,691$0.57$24,903.87 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/20/2024Guy Archibald InnesDirectorBuy150,000$0.67$100,500.00 (Data available from 1/1/2013 forward) VNRX Insider Trading Activity - Frequently Asked Questions Who is on VolitionRx's Insider Roster? The list of insiders at VolitionRx includes Cameron John Reynolds, Corp Ltd Eight, Gaetan Michel, Guy Archibald Innes, Jacob Vincent Micallef, Martin Charles Faulkes, Phillip Barnes, Rodney Gerard Rootsaert, and Salvatore Thomas Butera. Learn more on insiders at VNRX. What percentage of VolitionRx stock is owned by insiders? 10.40% of VolitionRx stock is owned by insiders. Learn more on VNRX's insider holdings. Which VolitionRx insiders have been buying company stock? The following insiders have purchased VNRX shares in the last 24 months: Cameron John Reynolds ($252,567.17), Gaetan Michel ($6,150.00), Guy Archibald Innes ($298,115.48), Jacob Vincent Micallef ($85,153.87), Martin Charles Faulkes ($12,436.48), Phillip Barnes ($6,500.00), Rodney Gerard Rootsaert ($6,000.00), and Salvatore Thomas Butera ($24,100.00). How much insider buying is happening at VolitionRx? Insiders have purchased a total of 1,099,800 VNRX shares in the last 24 months for a total of $691,023.00 bought. Which VolitionRx insiders have been selling company stock? The following insider sold VNRX shares in the last 24 months: Corp Ltd Eight ($33,000.00). How much insider selling is happening at VolitionRx? Insiders have sold a total of 40,000 VolitionRx shares in the last 24 months for a total of $33,000.00 sold. VolitionRx Key ExecutivesDr. Martin Charles Faulkes Ph.D. (Age 80)Executive Chairman Compensation: $239.51kMr. Cameron Reynolds MBA (Age 53)Founder, CEO, President & Director Compensation: $572.43kDr. Gaetan Michel Ph.D. (Age 50)Chief Operating Officer Compensation: $518.15kDr. Salvatore Thomas Butera DVM (Age 72)Chief Executive Officer of Volition Veterinary Diagnostics Development LLC Compensation: $477.25kMr. Terig Hughes (Age 53)CFO & Treasurer Compensation: $338.74kDr. Jacob Vincent Micallef MBA (Age 68)Ph.D., Chief Scientific Officer Compensation: $571.55k1 recent tradesMr. Nicholas Plummer (Age 53)Group General Counsel Ms. Louise Batchelor Day (Age 52)Group Chief Marketing & Communications Officer Mr. Thomas BygottSales & Marketing DirectorMr. Gael Forterre M.B.A. (Age 42)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies LFCR Insider Selling INZY Insider Selling HRTX Insider Selling SGMT Insider Selling NMRA Insider Selling MNPR Insider Selling DBVT Insider Selling DRUG Insider Selling ALLO Insider Selling GALT Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NYSE:VNRX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VNRX Stock Alerts